logo
Plus   Neg
Share
Email

Altria Group Completes Acquisition Of 45% Stake In Cronos Group - Quick Facts

Altria Group, Inc. (MO) announced Friday the completion of the acquisition of a 45 percent ownership interest in Toronto, Canada-based cannabinoid company Cronos Group Inc. (CRON, CRON.TO) for about $1.8 billion (about C$2.4 billion), following receipt of shareholder and Canadian regulatory approvals.

With the closure of this transaction, Altria has become the largest shareholder in Cronos Group.

Altria's investment represents an approximate 45% economic and voting interest in Cronos Group with a warrant to acquire additional ownership interest of 10 percent at a price of CAD $19.00 per share, exercisable over the next four years. The aggregate exercise price for the warrant is about $1.0 billion (about C$1.4 billion).

Under the terms of the transaction, Altria nominated four directors who were recently elected to serve on Cronos Group's seven member board: Kevin Crosthwaite, Jr., Murray Garnick, Bruce Gates and Bronwen Evans.

Altria expects to account for its investment in Cronos Group under the equity method of accounting. Altria will report its share of Cronos Group's results using a one-quarter lag because Cronos Group's results will not be available in time for Altria to record them in the concurrent period.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT